Stock Events

Stock Events

NeuroSense Therapeutics (NRSN) Q3 2023 Earnings

28NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.28

-0.15

-0.03

0.1

Details

Expected EPS

N/A

Actual EPS

0.1

Surprise EPS

0.1

Surprise Percent

+∞%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of 0.1 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.